Business
What Once Looked Like an Also-ran Therapy from Novartis Now Has a Chance to Compete with ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'What once looked like an also-ran therapy from Novartis now has a chance to compete with antiviral pills from Pfizer and Merck ...'
What once looked like an also-ran therapy from Novartis now has a chance to compete with antiviral pills from Pfizer and Merck https://t.co/JTtqs5H9SE— Bloomberg (@business) February 12, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Feb 12, 2022 11:16 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
